The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

Total Raised


Last Raised

$6.5M | 14 yrs ago

About Synvascular

Synvascular is a life science device company in Palo Alto

Synvascular Headquarter Location

3520 West Bayshore Road

Palo Alto, California, 94303,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Synvascular

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Synvascular is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

  • When was Synvascular founded?

    Synvascular was founded in 2007.

  • Where is Synvascular's headquarters?

    Synvascular's headquarters is located at 3520 West Bayshore Road, Palo Alto.

  • What is Synvascular's latest funding round?

    Synvascular's latest funding round is Series A.

  • How much did Synvascular raise?

    Synvascular raised a total of $6.5M.

  • Who are the investors of Synvascular?

    Investors of Synvascular include Kleiner Perkins Caufield & Byers and InterWest Partners.

  • Who are Synvascular's competitors?

    Competitors of Synvascular include Vaccinex, Perseus Proteomics, GANYMED Pharmaceuticals, Q Chip, Anterion Therapeutics and 8 more.

You May Also Like

Chiome Bioscience

Chiome Bioscience leverages the ADLib® System, a proprietary monoclonal antibody generating technology for drug development. The company also provides drug discovery support.

ASC Therapeutics Logo
ASC Therapeutics

ASC Therapeutic is a privately-held gene therapy company focused on developing transformative gene-based medicines for serious diseases.

Zebra Pharmaceuticals

Zebra Pharmaceuticals offers customized health products through nature and science.

Esperance Pharmaceuticals

Esperance Pharmaceuticals develops targeted anticancer drugs that selectively kill cancer cells without harming normal cells.


VGXI is a contract manufacturer of plasmid DNA. The company delivers flexibility, experience, reliability, and value to clients’ challenging programs. The company’s cGMP and non-cGMP products have passed rigorous international regulatory reviews.

Wrightwood Technologies

The company are a technology development and licensing firm with a strong focus on robotics and machine intelligence applications and their integration into industries such as pharmaceuticals and health care. The company take great pride in the company's diverse and knowledgeable staff, who make such ventures possible. Wrightwood Technologies Inc. aims to provide both the public and private sectors with technologies and services that improve efficiency, increase production, reduce costs, eliminate waste, and improve societies' over-all quality of life.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.